Dig the herders, display the Hottentots : the production and presentation of knowledge about the past

Bibliography: pages 120-131.Knowledge and History have for many years been sites of struggle in South Africa and academic versions of the past are being challenged with commitment by oppressed communities all over the world. Archaeologists, as producers of information about the past, are necessarily involved in such struggles. The aim of this research project has been to demonstrate that our constructions of the past are deeply embedded in the politics of production and presentation of knowledge. The manner in which information is presented to the public is integrally linked to the manner in which knowledge about the past is produced. These politics form a particular dynamic with the way people perceive themselves and others. By examining the specifics of the construction of a Hottentot icon, and its links with constructions of gatherer-hunter histories, I have also tackled issues such as the contingency of research interpretations, the subjectivity of researchers, the myth of "scientific objectivity", and knowledge as a site of struggle in South Africa. I have also examined the links between writing, description, sexism, racism and colonialism, and educational methods and the authority of the expert. It is in the use of authoritative techniques in the production of knowledge and in the presentation of research interpretations that the problem lies. Authoritative techniques are pervasive and powerful, and function to inhibit public challenges to academic knowledge. The weight of notions such as science, objectivity and truth - which back up most presentations of academic knowledge - disallow the empowerment of communities towards participation in the processes of producing knowledge. I advocate a shift towards production and presentation that uses instead methods that encourage traditionally powerless communities to play an active role in the construction of their histories. I have focussed on the construction of authoritative herder histories, in both museums and other public media, in order to examine the role of archaeologists in struggles around the past. Whether we are conscious participants in these struggles, or whether we adopt a stance of objective neutrality, the information we produce has a powerful and important effect on the way in which people make sense of ourselves. A People's Archaeology - an archaeology dependent on community participation in research, interpretation and presentation - will require the development of democratic research methods. And this necessitates the initial steps of demystifying the process whereby academic knowledge is produced, and the development of an understanding of the origins of historical symbols. This project is a contribution to these debates, and will hopefully be, in some way, a contribution to the process of formulating different research methods towards the development of a People's Archaeology

Semantic, phonological and episodic representations in verbal immediate serial recall

Psycholinguistic frameworks provide contemporary accounts of immediate serial recall (e.g., N. Martin & Saffran, 1997; R. C. Martin, Lesch, & Bartha, 1999). These models emphasise the inclusion of semantic/associative and phonological representations in verbal short-term memory but have difficulty explaining how serial order is represented and maintained. Conversely, computational models of immediate serial recall (e.g., Brown, Preece, & Hulme, 2000; Henson, 1998b; Lewandowsky & Farrell, 2008b; Page & Norris, 1998) have typically concentrated on the role of temporary episodic representations on short-term recall but have trouble accounting for the influence of multiple representations on performance. The aim of this research was to combine these two lines of research to form a more integrative approach to immediate serial recall. The intention was to contribute to current understandings of verbal short-term memory by exploring how the binding of semantic/associative, phonological and episodic representations would influence immediate serial recall..

Promoting Positive Youth Development: Relational Data Analysis (RDA)

This article provides an overview of the origins and use of relational data analysis (RDA). RDA is a multidimensional, multiphasic framework for unifying data analytic strategies across dimensions (quantitative/qualitative, causal/structural, observation/interpretation, etc.) and phases of analyses (conceptual, theoretical, and research analyses). RDA was developed within a relational metatheoretical methodological framework for overcoming the splits that have historically characterized methodological metatheory. The aim was to formulate a practical, ready-at-hand framework that the developmental scientist could use to unify the analysis of developmental change in real life “applied” settings as well as clinic and laboratory settings

Attitudes toward e-mental health services in a community sample of adults: online survey

Background: Despite evidence that e-mental health services are effective, consumer preferences still appear to be in favor of face-to-face services. However, the theory of planned behavior (TPB) suggests that cognitive intentions are more proximal to behavior and thus may have a more direct influence on service use. Investigating individual characteristics that influence both preferences and intentions to use e-mental health services is important for better understanding factors that might impede or facilitate the use of these services. Objective: This study explores predictors of preferences and intentions to access e-mental health services relative to face-to-face services. Five domains were investigated (demographics, technology factors, personality, psychopathology, and beliefs), identified from previous studies and informed by the Internet interventions model. We expected that more participants would report intentions to use e-mental health services relative to reported preferences for this type of support and that these 5 domains would be significantly associated with both intentions and preferences toward online services. Methods: A mixed sample of 308 community members and university students was recruited through social media and the host institution in Australia. Ages ranged between 17 and 68 years, and 82.5% (254/308) were female. Respondents completed an online survey. Chi-square analysis and t tests were used to explore group differences, and logistic regression models were employed to explore factors predicting preferences and intentions. Results: Most respondents (85.7%, 264/308) preferred face-to-face services over e-mental health services. Relative to preferences, a larger proportion of respondents (39.6%, 122/308) endorsed intentions to use e-mental health services if experiencing mental health difficulties in the future. In terms of the 5 predictor domains, 95% CIs of odds ratios (OR) derived from bootstrapped standard errors suggested that prior experience with online services significantly predicted intentions to use self-help (95% CI 2.08-16.24) and therapist-assisted (95% CI 1.71-11.90) online services in future. Being older predicted increased intentions to use therapist-assisted online services in future (95% CI 1.01-1.06), as did more confidence using computers and the Internet (95% CI 1.06-2.69). Technology confidence was also found to predict greater preference for online services versus face-to-face options (95% CI 1.24-4.82), whereas higher doctor-related locus of control, or LOC (95% CI 0.76-0.95), and extraversion (95% CI 0.88-1.00) were predictive of lower likelihood of preferring online services relative to face-to-face services. Conclusions: Despite generally low reported preferences toward e-mental health services, intentions to access these services are higher, raising the question of how to best encourage translation of intentions into behavior (ie, actual use of programs). Strategies designed to ease people into new Internet-based mental health programs (to enhance confidence and familiarity) may be important for increasing the likelihood that they will return to such programs later

Genome-wide association study of breast density among women of African ancestry

Breast density, the amount of fibroglandular versus fatty tissue in the breast, is a strong breast cancer risk factor. Understanding genetic factors associated with breast density may help in clarifying mechanisms by which breast density increases cancer risk. To date, 50 genetic loci have been associated with breast density, however, these studies were performed among predominantly European ancestry populations. We utilized a cohort of women aged 40-85 years who underwent screening mammography and had genetic information available from the Penn Medicine BioBank to conduct a Genome-Wide Association Study (GWAS) of breast density among 1323 women of African ancestry. For each mammogram, the publicly available LIBRA software was used to quantify dense area and area percent density. We identified 34 significant loci associated with dense area and area percent density, with the strongest signals i

D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes

Certain D2 dopamine receptor Taq 1A genotypes (A1A1, A1A2) have been associated with obesity and substance abuse. We hypothesized that their presence would be associated with reduced efficacy of dietary interventions in individuals with type 2 diabetes

New genetic loci link adipose and insulin biology to body fat distribution.

Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, here we conduct genome-wide association meta-analyses of traits related to waist and hip circumferences in up to 224,459 individuals. We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), and an additional 19 loci newly associated with related waist and hip circumference measures (P < 5 × 10(-8)). In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significant sexual dimorphism, 19 of which display a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

Build it, but will they come? Investigating the Australian tourists’ risk perceptions and attitudes towards the UAE

The Middle East region is becoming increasingly renowned for its tourism activity and continues to enjoy steady growth as a tourism destination. One of the most aspiring Middle Eastern destinations is the United Arab Emirates and the city of Dubai. Despite this destination’s interest in attracting international tourists from potential markets such as Australia, little is known in terms of how the Australian travel market views this up and coming tourism hub. Using potential travellers from the Australia market, the results from this exploratory study indicate that the UAE and in particular Dubai does not hold a favourable position in the minds of Australian tourists. Various types of risk are associated with travel to the region and the city of Dubai is described as a destination that possesses a lack of destination identity. Implications for promotional efforts and recommendations for tourism planners are discussed